GLP-1 medications have grown popular in recent years for weight loss, but one doctor has found another use: combating alcohol and drug addiction. Dr. Steven

Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month  CNBC Novo Undercuts Lilly’s Obesity Drug Price for Cash-Pay Patients  Bloomberg.com Novo Nordisk further lowers

Eli Lilly LLY and Johnson & Johnson JNJ are major U.S. healthcare companies within the pharmaceutical/biotech space. Both companies have a strong presence in oncology, immunology

Novo Undercuts Lilly’s Obesity Drug Price for Cash-Pay Patients  Bloomberg.com Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month  CNBC Novo Nordisk further lowers

Among GLP-1 users, more than half said they will eat smaller portions and skip more treats this festive season

Macter International Ltd has emerged from the latest results season with a clear message for investors: momentum is back in branded generics, new biologics are

GLP-1 drugs like tirzepatide and semaglutide offer powerful weight-loss effects but come with unanswered questions about long-term safety, side effects, and global accessibility. Researchers stress

GLP-1 drugs may protect the liver but raise blood alcohol levels. Yale researchers are investigating how this dual effect impacts health. Anti-obesity drugs such as

Among GLP-1 users, more than half said they will eat smaller portions and skip more treats this festive season

MORE than 170 deaths have been linked to fat jabs, it has been revealed. Drug watchdogs have received 173 fatal reports related to GLP-1 injections

People are risking their health by injecting a highly potent but unapproved weight loss jab called retatrutide, sometimes called the Godzilla of weight loss injections.

From Thanksgiving Day through Cyber Monday, get 40% off at http://www.cozyearth.com with code DOCTORMIKE. It’s the best deal of the year!” I’ll teach you how

A common diabetes drug could dampen some of the key benefits of exercise, a new study has found. Researchers from Rutgers University discovered that adults

Mochi Health is changing how people approach weight loss and wellness by offering a medical, evidence-based platform through its easy-to-use iOS app. Built to deliver

We recently published 11 Stocks Jim Cramer Talked About. Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim Cramer recently discussed. Cramer has

GLP-1 medications silence “food noise” for many, but have high discontinuation rates and significant side effects. Is there a better way?

The “Before” and “After” photos are breaking the internet. Facebook groups, Reddit threads and gobs of other social media posts sing its praises. But there

Pharmaceuticals, Vol. 18, Pages 1738: The GLP-1 Analog Liraglutide Reduces Fever Through Sex-Dependent Neuroinflammatory Modulation Pharmaceuticals doi: 10.3390/ph18111738 Authors: Gabriela L. Soares de Sousa Ester

Eli Lilly CEO David Ricks Raquel Natalicchio/Houston Chronicle via Getty Images Eli Lilly CEO David Ricks says AI helps him stay up to date on

Cutting-edge AI meets GLP-1 nutrition meets dining out — empowering users to eat out or order in with confidence, and helping restaurants increase revenue from

Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results. Will dialysis and organ transplants

In this image taken from video, an IV infusion is administered at Pure Alchemy Wellness, Tuesday, Nov. 11, 2025, in Chula Vista, Calif. (AP Photo/Javier

Welcome to this week’s Food Exec Brief, a roundup of the most important news shaping food and beverage manufacturing, from agentic AI deployment and next-generation

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning! If you’re still

President Donald Trump on Thursday announced deals with Eli Lilly and Novo Nordisk to slash the prices of some of their obesity drugs, including upcoming

KFF Health Tracking Poll: Prescription Drug Costs, Views on Trump Administration Actions, and GLP-1 Use  KFF

I am preparing a systematic review for journal submission that examines how GLP-1 receptor agonists perform against alternative treatments in managing pediatric obesity. The manuscript

Hospitals may face renewed supply chain pressure heading into 2026, including rising material costs to tariff-driven disruptions. Here are seven developments leaders should watch: 1.

(MedPage Today) — Patients with colon cancer and a history of treatment with GLP-1 receptor agonists for obesity had a 5-year mortality rate that was

By MATTHEW PERRONE, Associated Press Health Writer WASHINGTON (AP) — More Americans are injecting themselves with unapproved chemicals that are pitched as ways to build

Presenting the latest installment of W’s column By the Numbers, where we explore a given field—from art and fashion to music and movies—through the essential

Eli Lilly and Company LLY is one of the two companies that dominate the booming diabetes and obesity space, driven by its successful GLP-1 therapies

Meghan Trainor is defending her weight loss. In a new interview, the 31-year-old “Made You Look” singer fired back at body-shamers who have “attacked” her

Healthcare, Vol. 13, Pages 2922: Semaglutide in Diabetic Kidney Disease: Integrating Clinical Evidence with Mechanistic Insights Healthcare doi: 10.3390/healthcare13222922 Authors: Faten F. Bin Bin Dayel